Valuation: Provexis plc

Market Cap 25.22M 34.03M 29.44M 27.49M 47.43M 3.24B 48.19M 323M 127M 1.62B 128M 125M 5.37B P/E 2024
-20.9x
P/E 2025 -22.6x
Enterprise Value 24.51M 33.08M 28.61M 26.72M 46.1M 3.15B 46.83M 313M 123M 1.58B 124M 121M 5.22B EV / Sales 2024
17x
EV / Sales 2025 7.62x
Free-Float
79.16%
Yield 2024 *
-
Yield 2025 -
1 week-3.93%
Current month-3.93%
1 month-11.65%
3 months+8.91%
6 months-7.17%
Current year+22.22%
1 week 0.95
Extreme 0.95
1.25
1 month 0.95
Extreme 0.95
1.35
Current year 0.77
Extreme 0.77
1.55
1 year 0.55
Extreme 0.55
1.55
3 years 0.4
Extreme 0.4
1.55
5 years 0.4
Extreme 0.4
1.55
10 years 0.2
Extreme 0.2
1.55
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer 52 31/12/1999
Director TitleAgeSince
Director/Board Member - 10/11/2010
Chairman 79 31/05/2005
Director/Board Member 52 11/04/2019
Date Insider Type Main position Quantity % Market Cap.
07/01/25 Free

Chief Executive Officer

30,000,000 1.2788%
24/01/23 Free

Chief Executive Officer

17,000,000 0.7665%
24/01/23 Free

Chief Technology Officer

17,000,000 0.7665%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.93%+49.25%+76.00% 34.82M
+0.46%+1.93%+34.94%+86.98% 13.92B
+2.95%+8.31%-19.25%+301.10% 8.5B
-0.10%-3.35%-15.35%-50.39% 2.5B
+9.59%+9.99%+21.31%+66.65% 1.35B
+7.78%+5.72%-22.08%-20.04% 1.35B
-4.54%-6.70%-70.35%-69.23% 1.34B
+7.30%-0.56%+38.76%-32.40% 1.29B
-3.33%+4.55%-34.07% - 1.17B
-0.63%+9.04%-62.31%-70.16% 982M
Average +1.95%+1.69%-7.92%+32.06% 3.25B
Weighted average by Cap. +1.65%+3.88%+4.29%+112.05%

Financials

2024 2025
Net sales 802K 1.08M 936K 874K 1.51M 103M 1.53M 10.26M 4.03M 51.63M 4.06M 3.98M 171M 1.29M 1.74M 1.51M 1.41M 2.43M 166M 2.47M 16.53M 6.49M 83.19M 6.55M 6.41M 275M
Net income -586K -791K -684K -639K -1.1M -75.29M -1.12M -7.5M -2.94M -37.74M -2.97M -2.91M -125M -453K -611K -528K -494K -852K -58.14M -865K -5.79M -2.27M -29.14M -2.29M -2.24M -96.35M
Net Debt -189K -256K -221K -206K -356K -24.32M -362K -2.42M -951K -12.19M -960K -939K -40.3M -708K -956K -827K -772K -1.33M -90.94M -1.35M -9.06M -3.55M -45.58M -3.59M -3.51M -151M
Logo Provexis plc
Provexis plc is a United Kingdom-based company that develops, licenses and sells the proprietary, scientifically proven Fruitflow heart-health functional food ingredient. Fruitflow is a natural extract from tomatoes which has been shown in human trials to reduce the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can lead to heart attack and stroke. The extract is available as a spray-dried powder, and it can be included in a broad range of food, beverage and dietary supplement formats. Fruittflow is a highly concentrated form of bioactives which is lycopene-free and contains over 30 known antiplatelet compounds. The Company also offers Fruitflow+, Omega-3, and dietary supplement products which are sold directly to consumers. In addition, the Company supplies Fruitflow as an ingredient to brand owners in the food, beverage, and supplement sectors through DSM Nutritional Products’ distribution network.
Employees
2
Date Price Change Volume
07/08/26 GBX 1.100 0.00% 27,718
06/08/26 GBX 1.100 -2.22% 4,344,921
05/08/26 GBX 1.125 +2.27% 1,843,416
04/08/26 GBX 1.100 0.00% 924,051
03/08/26 GBX 1.100 -3.93% 659,000